AbbaDox and Merge Healthcare Solutions Announce Strategic Partnership for Enhanced Radiology Workflow Solutions

AbbaDox, a leading provider of cloud-based healthcare solutions, is pleased to announce a strategic relationship with Merge Healthcare Solutions to deliv...

July 26, 2024 | Friday | News
Tata 1mg Labs Achieves 99.48% Score in CAP Proficiency Testing, Setting New Standards for Diagnostic Excellence

Tata 1mg Labs, a leader in diagnostic excellence, is proud to announce that it has achieved an outstanding score of 99.48% in the College of American Pat...

July 25, 2024 | Thursday | News
Lario Therapeutics Receives $6 Million Grant from MJFF for Innovative Parkinson’s Disease Research

Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Par...

July 23, 2024 | Tuesday | News
Valneva Secures $41.3 Million from CEPI and EU to Expand Access to Chikungunya Vaccine IXCHIQ®

Valneva to receive up to $41.3 million from CEPI and the European Union to expand access to chikungunya vaccine, IXCHIQ® Funding will support clin...

July 22, 2024 | Monday | News
Innovent Biologics Announces Phase 3 Success for Mazdutide in Treating Type 2 Diabetes

Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of on...

July 22, 2024 | Monday | News
Wolters Kluwer Health Launches Rx Transitions for Mental Health to Aid Primary Care Providers Amid Mental Health Professional Shortage

The overwhelming demand for mental health care and the shortage of providers specifically trained in it have left primary care providers (PCPs) on the fr...

July 18, 2024 | Thursday | News
AstraZeneca Completes Acquisition of Amolyt Pharma for $1.05 Billion

  Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related di...

July 15, 2024 | Monday | News
Taiwan's Senhwa Biosciences Submits IND to US FDA for Phase I/II Study of Silmitasertib in Pediatric Cancer Treatment

  Senhwa Biosciences, Inc. (TPEx: 6492), announced IND Submission to US FDA for the Phase I/II study of Silmitasertib (CX-4945) in combination with c...

July 12, 2024 | Friday | News
Eisai and Biogen Announce Approval of Alzheimer’s Treatment LEQEMBI® in Israel

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher...

July 12, 2024 | Friday | News
BioArctic AB’s Partner Eisai Announces Approval of Leqembi® (樂意保®) for Alzheimer’s Disease Treatment in Hong Kong

BioArctic AB  is pleased to announce that its partner, Eisai, has received approval from the Department of Health in Hong Kong for Leqembi® (bra...

July 11, 2024 | Thursday | News
Epsilogen Receives MHRA Approval for Phase Ib Trial of MOv18 IgE in Treating Platinum-Resistant Ovarian Cancer

Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces that the Clinical Trial Application f...

July 09, 2024 | Tuesday | News
Roche Receives CE Mark for Accu-Chek® SmartGuide CGM Solution, Empowering Diabetes Management in Europe

Roche  announced  that it has received the CE Mark for its Accu-Chek® SmartGuide continuous glucose monitoring (CGM) solution. This signifi...

July 09, 2024 | Tuesday | News
Ecolab Launches First-Ever 100% Plastic-Free Disinfectant Wipe for Hospitals

Ecolab solutions help clean 15 million patient rooms and 3.5 billion surgical instruments. To help healthcare providers deliver a clean and safe enviro...

July 04, 2024 | Thursday | News
Dawn Health Partners with Merck to Develop Digital Solution for Growth Hormone Disorders

Dawn Health, the digital health company pioneering patient-first innovation, has announced they are working with leading global pharmaceutical company, M...

July 01, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close